Your session is about to expire
← Back to Search
Telehealth Intervention for Ovarian Cancer-Related Fatigue
Study Summary
This trialis exploring if a 6-week online program can help ovarian cancer patients with fatigue caused by their meds to reduce fatigue's impact on daily life.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there currently opportunities for participants to join this clinical experiment?
"The clinicaltrials.gov portal does not have evidence of any open recruitment for this trial; it was initially posted on December 2, 2020 and last updated October 13th 2022. Nevertheless, there are currently 917 other medical studies enrolling patients at the present time."
What is the ultimate goal of this clinical research endeavor?
"The primary outcome being monitored by AstraZeneca, the study sponsor, is Fatigue Change over a period of 12 weeks. Secondary outcomes are Physical well-being (measured on FACT-O's 5 point Likert Scale with scores ranging 0 to 28), Emotional Well-being (also measured on FACT-O's 5 point Likert Scale with score range from 0 to 28) and Functional Well-Being (again evaluated by FACT - O's five point scale that ranges between 0 and 28)."
Share this study with friends
Copy Link
Messenger